Business Description
Sophia Genetics SA
NAICS : 923120
SIC : 7372
ISIN : CH1125843347
Description
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 5.95 | |||||
Equity-to-Asset | 0.73 | |||||
Debt-to-Equity | 0.13 | |||||
Debt-to-EBITDA | -0.25 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 0.69 | |||||
Beneish M-Score | -3.03 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 17.7 | |||||
3-Year EBITDA Growth Rate | -10.7 | |||||
3-Year EPS without NRI Growth Rate | -13.6 | |||||
3-Year FCF Growth Rate | -7 | |||||
3-Year Book Growth Rate | 3.5 | |||||
Future 3-5Y Total Revenue Growth Rate | 28.42 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 51.78 | |||||
9-Day RSI | 53.57 | |||||
14-Day RSI | 53.23 | |||||
6-1 Month Momentum % | 19.07 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.14 | |||||
Quick Ratio | 3.94 | |||||
Cash Ratio | 3.44 | |||||
Days Inventory | 96.58 | |||||
Days Sales Outstanding | 41.46 | |||||
Days Payable | 102.15 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -10.8 | |||||
Shareholder Yield % | -0.48 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 67.97 | |||||
Operating Margin % | -115.75 | |||||
Net Margin % | -113.71 | |||||
FCF Margin % | -88.94 | |||||
ROE % | -45.69 | |||||
ROA % | -34.84 | |||||
ROIC % | -110.36 | |||||
ROC (Joel Greenblatt) % | -342.86 | |||||
ROCE % | -43.37 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 5.01 | |||||
PB Ratio | 2.45 | |||||
Price-to-Tangible-Book | 3.05 | |||||
EV-to-EBIT | -3.07 | |||||
EV-to-Forward-EBIT | -4.93 | |||||
EV-to-EBITDA | -3.45 | |||||
EV-to-Forward-EBITDA | -6.48 | |||||
EV-to-Revenue | 3.7 | |||||
EV-to-Forward-Revenue | 3.02 | |||||
EV-to-FCF | -4.16 | |||||
Price-to-Net-Current-Asset-Value | 4.2 | |||||
Price-to-Net-Cash | 5.8 | |||||
Earnings Yield (Greenblatt) % | -32.57 | |||||
FCF Yield % | -17.64 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sophia Genetics SA Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 59.321 | ||
EPS (TTM) (€) | -1.034 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 53.23 | ||
14-Day ATR (€) | 0.147972 | ||
20-Day SMA (€) | 4.384 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (€) | 2.08 - 5.1 | ||
Shares Outstanding (Mil) | 65.38 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Sophia Genetics SA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Sophia Genetics SA Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Sophia Genetics SA Frequently Asked Questions
What is Sophia Genetics SA(STU:90B)'s stock price today?
The current price of STU:90B is €4.58. The 52 week high of STU:90B is €5.10 and 52 week low is €2.08.
When is next earnings date of Sophia Genetics SA(STU:90B)?
The next earnings date of Sophia Genetics SA(STU:90B) is 2024-08-08 Est..
Does Sophia Genetics SA(STU:90B) pay dividends? If so, how much?
Sophia Genetics SA(STU:90B) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |